These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15850068)

  • 1. Correlation between voiding and erectile function in patients with symptomatic benign prostatic hyperplasia.
    Huang WJ; Chen KK; Chang LS
    J Chin Med Assoc; 2005 Apr; 68(4):178-82. PubMed ID: 15850068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
    Shao Q; Song J; Guo YW; Lu WC; Du LD
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia.
    Marzano L; Thiounn N; Pereira H; Pellerin O; Dariane C; Del Giudice C; Amouyal G; Dean C; Sapoval M
    Cardiovasc Intervent Radiol; 2020 Aug; 43(8):1202-1207. PubMed ID: 32494835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
    J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2016 Dec; 70(6):449-452. PubMed ID: 28210019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study.
    Gacci M; Bartoletti R; Figlioli S; Sarti E; Eisner B; Boddi V; Rizzo M
    BJU Int; 2003 Feb; 91(3):196-200. PubMed ID: 12581003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.
    Kardasevic A; Milicevic S
    Med Arch; 2017 Feb; 71(1):32-36. PubMed ID: 28428671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function.
    Jung JH; Jae SU; Kam SC; Hyun JS
    J Sex Med; 2009 Aug; 6(8):2299-304. PubMed ID: 19493292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires.
    Nakamura M; Fujimura T; Nagata M; Hosoda C; Suzuki M; Fukuhara H; Enomoto Y; Nishimatsu H; Kume H; Igawa Y; Homma Y
    Aging Male; 2012 Jun; 15(2):111-4. PubMed ID: 22283118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting.
    Mamoulakis C; Skolarikos A; Schulze M; Scoffone CM; Rassweiler JJ; Alivizatos G; Scarpa RM; de la Rosette JJ
    BJU Int; 2013 Jul; 112(1):109-20. PubMed ID: 23490008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy.
    Helfand BT; Glaser AP; Rimar K; Zargaroff S; Hedges J; McGuire BB; Catalona WJ; McVary KT
    BJU Int; 2013 Jan; 111(1):38-43. PubMed ID: 22639942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.